Sequenom Hammered by Market, Analysts

A day after the firm's CEO and senior VP of R&D were fired and other executives resigned, Sequenom's shares took a beating. A lack of clarity from Sequenom's conference call also had analysts concerned.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.